Our data suggested PVT1 was an oncogene in bladder cancer and the tetracycline-inducible shRNA targeting PVT1 inhibited the expression of PVT1 in a dosage-dependent manner, and suppressed cell growth and induced apoptosis in bladder cancer cells. This evidence concerns the gene PVT1 and urinary bladder cancer.